[Internet]. [cited 2018 Feb 25];Available from: https://www.volksgezondheidenzorg.info/ onderwerp/coronaire-hartziekten/cijfers-context/huidige-situatie#!node-prevalentie-en- nieuwe-gevallen-van-coronaire-hartziekten
29. Crijns HJ, Van Gelder IC, Van Gilst WH, Hillege H, Gosselink AM, Lie KI. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol. 1991;68:335–41.
30. AFFIRM Investigators. Atrial Fibrillation Follow-up Investigation of Rhythm Management. Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study. Am Heart J. 2002;143:991– 1001.
31. Lip GY, Beevers DG. ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation. BMJ. 1995;311:1361–3.
32. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98:476– 84.
33. Hohnloser SH, Crijns HJGM, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ. Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation. N Engl J Med. 2009;360:668– 678.
34. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KAA, Califf RM, ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.
35. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener H-C, Joyner CD, Wallentin L, RE-LY Steering Committee and Investigators. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med. 2009;361:1139–1151.
36. Van Gelder IC, Groenveld HF, Crijns HJGM, Tuininga YS, Tijssen JGP, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, Van Veldhuisen DJ, Van den Berg MP, RACE II Investigators. Lenient versus Strict Rate Control in Patients with Atrial Fibrillation. N Engl J Med. 2010;362:1363–1373.
37. Kralev S, Schneider K, Lang S, Süselbeck T, Borggrefe M. Incidence and Severity of Coronary Artery Disease in Patients with Atrial Fibrillation Undergoing First-Time Coronary Angiography. PLoS One. 2011;6:e24964.
38. Otterstad JE, Kirwan B-A, Lubsen J, De Brouwer S, Fox KAA, Corell P, Poole-Wilson PA, Action Investigators. Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease. Scand Cardiovasc J. 2006;40:152–9.
39. Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol. 1988;61:714–7.
40. Haddad AH, Prchkov VK, Dean DC. Chronic atrial fibrillation and coronary artery disease. J Electrocardiol. 1978;11:67–9.
41. Gorenek B, Lundqvist CB, Terradellas JB, Camm AJ, Hindricks G, Huber K, Kirchhof P, Kuck KH, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz RR, Valgimigli M, Vos MA, Vrints C, Zeymer U. Cardiac arrhythmias in acute coronary syndromes: Position paper from the joint EHRA, ACCA, and EAPCI task force. Eur Hear J Acute Cardiovasc Care. 2015;4:386.
42. Dumas F, Cariou A, Manzo-Silberman S, Grimaldi D, Vivien B, Rosencher J, Empana J-P, Carli P, Mira J-P, Jouven X, Spaulding C. Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry. Circ Cardiovasc Interv. 2010;3:200–7.
43. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Hlatky MA, Granger CB, Hammill SC, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Heart Rhythm. 2017; 44. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial
fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol. 1994;74:236–241. 45. Diker E, Aydogdu S, Ozdemir M, Kural T, Polat K, Cehreli S, Erdogan A, Göksel S. Prevalence and
predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol. 1996;77:96–8. 46. Rowe JC, Bland EF, Sprague HB, White PD. The course of mitral stenosis without surgery: ten- and
twenty-year perspectives. Ann Intern Med. 1960;52:741–9.
47. Olesen KH. The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J. 1962;24:349–57.
48. Grigioni F, Avierinos J-F, Ling LH, Scott CG, Bailey KR, Tajik AJ, Frye RL, Enriquez-Sarano M. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol. 2002;40:84–92.
49. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis ASA, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Esquivias GB, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GYH, Manolis ASA, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962.
50. Gertz ZM, Raina A, Saghy L, Zado ES, Callans DJ, Marchlinski FE, Keane MG, Silvestry FE. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol. 2011;58.
51. Zhou X, Otsuji Y, Yoshifuku S, Yuasa T, Zhang H, Takasaki K, Matsukida K, Kisanuki A, Minagoe S, Tei C. Impact of atrial fibrillation on tricuspid and mitral annular dilatation and valvular regurgitation. Circ J. 2002;66:913–6.
52. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, Roffi M, Alfieri O, Agewall S, Ahlsson A, Barbato E, Bueno H, Collet JP, Coman IM, Czerny M, Delgado V, Fitzsimons D, Folliguet T, Gaemperli O, Habib G, Harringer W, Haude
01
M, Hindricks G, Katus HA, Knuuti J, Kolh P, Leclercq C, McDonagh TA, Piepoli MF, Pierard LA,Ponikowski P, Rosano GMC, Ruschitzka F, Shlyakhto E, Simpson IA, Sousa-Uva M, Stepinska J, Tarantini G, Tche D, Aboyans V, Baumgartner H, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–2786.
53. Généreux P, Stone GW, O’Gara PT, Marquis-Gravel G, Redfors B, Giustino G, Pibarot P, Bax JJ, Bonow RO, Leon MB. Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis. J Am Coll Cardiol. 2016;67:2263–88.
54. Nordhues BD, Siontis KC, Scott CG, Nkomo VT, Ackerman MJ, Asirvathan SJ, Noseworthy PA. Bileaflet Mitral Valve Prolapse and Risk of Ventricular Dysrhythmias and Death. J Cardiovasc Electrophysiol. 2016;27:463–468.
55. van der Linde D, Konings EEM, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJM, Roos- Hesselink JW. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58:2241–7.
56. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births: incidence and natural history. Circulation. 1970;43.
57. Egbe A, Uppu S, Lee S, Ho D, Srivastava S. Changing prevalence of severe congenital heart disease: A population-based study. Pediatr Cardiol. 2014;1232–1238.
58. Hoffman JI., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890– 1900.
59. Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, Daniels CJ, Deal BJ, Dearani JA, Groot N de, Dubin AM, Harris L, Janousek J, Kanter RKJKJKJ, Karpawich PP, Perry JC, Seslar SP, Shah MJ, Silka MJ, Triedman JK, Walsh EP, Warnes CA, de Groot N, Dubin AM, Harris L, Janousek J, Kanter RKJKJKJ, Karpawich PP, Perry JC, Seslar SP, Shah MJ, Silka MJ, Triedman JK, Walsh EP, Warnes CA. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease. Can J Cardiol. 2014;30:1–64.
60. de Groot NMS, Atary JZ, Blom NA, Schalij MJ. Long-Term Outcome After Ablative Therapy of Postoperative Atrial Tachyarrhythmia in Patients With Congenital Heart Disease and Characteristics of Atrial Tachyarrhythmia Recurrences. Circ Arrhythmia Electrophysiol. 2010;3:148– 54.
61. De Groot NMS, Lukac P, Blom NA, Van Kuijk JP, Pedersen AK, Hansen PS, Delacretaz E, Schalij MJ. Long-term outcome of ablative therapy of postoperative supraventricular tachycardias in patients with univentricular heart; A European multicenter study. Circ Arrhythmia Electrophysiol. 2009;2:242–248.
62. Teuwen CP, Taverne YJHJ, Houck C, Götte M, Brundel BJJM, Evertz R, Witsenburg M, Roos- Hesselink JW, Bogers AJJC, de Groot NMS, Molhoek SG, Ramdjan TTTK, Helbing WA, Kammeraad JAE, Dorman HGR, van Opstal JM, Konings TC, Vriend JWJ, van der Voort P. Tachyarrhythmia in patients with congenital heart disease: Inevitable destiny? Netherlands Hear J. 2016;24:161–170. 63. Triedman JK. Arrhythmias in adults with congenital heart disease. Heart. 2002;87:383–9.
64. De Groot NMS, Blom N, Vd Wall EE, Schalij MJ. Different mechanisms underlying consecutive, postoperative atrial tachyarrhythmias in a Fontan patient. Pacing Clin Electrophysiol. 2009;32:e18- 20.
65. Teuwen CP, Ramdjan TTTK, Götte M, Brundel BJJM, Evertz R, Vriend JWJ, Molhoek SG, Dorman HGR, van Opstal JM, Konings TC, Van Der Voort P, Delacretaz E, Houck C, Yaksh A, Jansz LJ, Witsenburg M, Roos-Hesselink JW, Triedman JK, Bogers AJJC, De Groot NMS. Time Course of Atrial Fibrillation in Patients with Congenital Heart Defects. Circ Arrhythmia Electrophysiol. 2015;8:1065–1072.
66. Wu MH, Lu CW, Chen HC, Chiu SN, Kao FY, Huang SK. Arrhythmic burdens in patients with tetralogy of Fallot: A national database study. Heart Rhythm. 2015;12:604–609.
67. Roos-Hesselink J, Perlroth MG, McGhie J, Spitaels S. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings. Circulation. 1995;91:2214–9.
68. Khairy P, Aboulhosn J, Gurvitz M, Opotowsky A, Mongeon F, Kay J, Valente A, Earing M, Lui G, Gersony D, Cook S, Ting J, Nickolaus M, Webb G, Landzberg M, Broberg C. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010;122:868–75.
69. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet (London, England). 2000;356:975–81. 70. Harrison DA, Siu SC, Hussain F, MacLoghlin CJ, Webb GD, Harris L. Sustained atrial arrhythmias in
adults late after repair of tetralogy of fallot. Am J Cardiol. 2001;87:584–8.
71. Khairy P, Balaji S. Cardiac Arrhythmias In Congenital Heart Diseases. Indian Pacing Electrophysiol J. 2009;9:299–317.
72. Luijten LWG, van den Bosch E, Duppen N, Tanke R, Roos-Hesselink J, Nijveld A, van Dijk A, Bogers AJJC, van Domburg R, Helbing WA. Long-term outcomes of transatrial-transpulmonary repair of tetralogy of Fallot. Eur J Cardiothorac Surg. 2015;47:527–34.
73. Padalino MA, Vida VL, Stellin G. Transatrial-Transpulmonary Repair of Tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2009;12:48–53.
74. Simon B V, Swartz MF, Egan M, Cholette JM, Gensini F, Alfieris GM. Use of a Dacron Annular Sparing Versus Limited Transannular Patch With Nominal Pulmonary Annular Expansion in Infants With Tetralogy of Fallot. Ann Thorac Surg. 2017;103:186–192.
75. Boni L, García E, Galletti L, Pérez A, Herrera D, Ramos V, Marianeschi SM, Comas J V. Current strategies in tetralogy of Fallot repair: pulmonary valve sparing and evolution of right ventricle/ left ventricle pressures ratio. Eur J Cardio-Thoracic Surg. 2009;35:885–890.
76. Palmen M, Klautz R, Braun J, Van Putte B. Behoefteraming cardiothoracaal chirurgen 2008-2018; rapport van de commissie in- en uitstroom van de Nederlandse vereniging voor thoraxchirurgie. 2010.
77. Ahlsson AJ, Bodin L, Lundblad OH, Englund AG. Postoperative Atrial Fibrillation is Not Correlated to C-Reactive Protein. Ann Thorac Surg. 2007;83:1332–1337.